BEAT
HeartBeam, Inc.
OpenVolumeMkt capP/EEPSDiv yield
Day – 52-wk –
Expected move
No implied move.
Next report
Last report
—
Largest filed tie
—
13F top-10 QoQ
Top fund weight
HeartBeam, Inc.
Expected move
No implied move.
Next report
Last report
—
Largest filed tie
—
13F top-10 QoQ
Top fund weight
HeartBeam, Inc.
0.56
HeartBeam has 8 disclosed suppliers and 1 disclosed customer in SEC filings.
SentenceThe VALID-ECG pivotal study was a multicenter trial that enrolled 198 patients across five clinical sites in the US, including Allegheny Health Network, Atlanta Heart Specialists, Mount Sinai Hospital, Northwell Health and Piedmont Heart Institute.
BEAT 10-Kaccession 0001193125-26-104080
SentenceThe VALID-ECG pivotal study was a multicenter trial that enrolled 198 patients across five clinical sites in the US, including Allegheny Health Network, Atlanta Heart Specialists, Mount Sinai Hospital, Northwell Health and Piedmont Heart Institute.
BEAT 10-Kaccession 0001193125-26-104080
SentenceThe study was a collaboration of Harvard Medical School Faculty at Beth Israel Deaconess Medical Center in Boston, MA, and Clinical Center of Serbia in Belgrade.
BEAT 10-Kaccession 0001193125-26-104080
SentenceThe study was a collaboration of Harvard Medical School Faculty at Beth Israel Deaconess Medical Center in Boston, MA, and Clinical Center of Serbia in Belgrade.
BEAT 10-Kaccession 0001193125-26-104080
SentenceOn March 10, 2026, the Company and the Icahn School of Medicine at Mount Sinai in New York ("Mount Sinai") entered into strategic AI collaboration to bring clinical-grade heart monitoring into the home.
BEAT 10-Kaccession 0001193125-26-104080
SentenceThe VALID-ECG pivotal study was a multicenter trial that enrolled 198 patients across five clinical sites in the US, including Allegheny Health Network, Atlanta Heart Specialists, Mount Sinai Hospital, Northwell Health and Piedmont Heart Institute.
BEAT 10-Kaccession 0001193125-26-104080
SentenceThe VALID-ECG pivotal study was a multicenter trial that enrolled 198 patients across five clinical sites in the US, including Allegheny Health Network, Atlanta Heart Specialists, Mount Sinai Hospital, Northwell Health and Piedmont Heart Institute.
BEAT 10-Kaccession 0001193125-26-104080
SentenceThe VALID-ECG pivotal study was a multicenter trial that enrolled 198 patients across five clinical sites in the US, including Allegheny Health Network, Atlanta Heart Specialists, Mount Sinai Hospital, Northwell Health and Piedmont Heart Institute.
BEAT 10-Kaccession 0001193125-26-104080
SentenceOn March 4, 2026, the Company announced ClearCardio as its first commercial customer.
BEAT 10-Kaccession 0001193125-26-104080